ey0018.9-7 | Surveillance strategies of endocrine complications | ESPEYB18
A Cattoni
, F Parissone
, I Porcari
, S Molinari
, N Masera
, M Franchi
, S Cesaro
, R Gaudino
, P Passoni
, A. alessandro.cattoni@unimib.it Balduzzi
Blood Rev. 2021; 45: 100730. https://pubmed.ncbi.nlm.nih.gov/32654893/This practical treatment protocol was developed by an experienced multidisciplinary team following a critical and updated systematic review of the literature.Hypogonadism is a common finding after antineoplastic treatment. It can either result from a primary gonadal disorder (due to pelvic irradiati...